Zobrazeno 1 - 10
of 374
pro vyhledávání: '"S. W. SCHALM"'
Publikováno v:
Journal of Hepatology. 33:543-548
Traditionally, autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) are regarded as separate disease entities. We report on a group of patients that suggests the existence of an overlap syndrome of the two conditions and on the prevale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63bc6c278d32c98efa74024cb318866
https://doi.org/10.1034/j.1600-0641.2000.033004543.x
https://doi.org/10.1034/j.1600-0641.2000.033004543.x
Publikováno v:
Hepatology, 26, 1338-1342. John Wiley & Sons Ltd.
The aim of this study was to evaluate whether interferon alfa (IFN-alpha) treatment-associated virological and biochemical remission improves survival in a cohort of 90 white patients with compensated cirrhosis caused by hepatitis B (Child A) followe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a0fee87e287a10a1b7ec1027d390b8
https://doi.org/10.1002/hep.510260536
https://doi.org/10.1002/hep.510260536
Autor:
S W, Schalm
Publikováno v:
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie. 71(1-2)
The concept of antiviral therapy with interferon for chronic hepatitis B emerged in the middle of the seventies and was supported by the suppressive effect of human interferon on HBV-DNA polymerase levels in 3 patients. This effect of leukocyte inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eef616c37264ba30f45428489d8cef39
https://pubmed.ncbi.nlm.nih.gov/19739400
https://pubmed.ncbi.nlm.nih.gov/19739400
Autor:
E H C J, Buster, K J, van Erpecum, S W, Schalm, H L, Zaaijer, J T, Brouwer, H C, Gelderblom, R J, de Knegt, C, Minke Bakker, H W, Reesink, H L A, Janssen
Publikováno v:
The Netherlands journal of medicine. 66(7)
The development of this guideline was initiated and coordinated by the Netherlands Association of Gastroenterologists and Hepatologists (Nederlandse Vereniging van Maag-Darm-Leverartsen). The aim is the establishment of national standards in the eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9b43b3df7d33281771e47dabfb6ce71
https://pubmed.ncbi.nlm.nih.gov/18663260
https://pubmed.ncbi.nlm.nih.gov/18663260
Publikováno v:
European Journal of Clinical Investigation. 20:540-545
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8724a3827da12a5ee98bd94a861c54
https://doi.org/10.1111/j.1365-2362.1990.tb01924.x
https://doi.org/10.1111/j.1365-2362.1990.tb01924.x
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 151(9)
Since hepatitis C can be treated more and more successfully, treatment should be considered in every patient. In some of the patients infected by viral genotype I, the duration of treatment can be shortened: 24 weeks instead of 48 weeks. Maintaining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f00c94c619dc80c1b52ddf063e1bf32c
https://pubmed.ncbi.nlm.nih.gov/17373393
https://pubmed.ncbi.nlm.nih.gov/17373393
Autor:
S. W. Schalm
Publikováno v:
Falk Symposium ISBN: 9781402028960
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ea173813a396007b8d06e0d5ed2e36
https://doi.org/10.1007/1-4020-2916-0_10
https://doi.org/10.1007/1-4020-2916-0_10
Autor:
J W Wladimiroff, S W Schalm, J A Mazel, R A Heijtink, A S M Nuijten, P. M. Grosheide, G. C. M. L. Christiaens
Publikováno v:
BMJ. 311:1197-1199
Objective: To develop a low cost, high compliance screening programme for identification of carriers of hepatitis B surface antigen in the obstetric population of the Netherlands. Design: A seven year open, descriptive study of screening for hepatiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5151e0078b94502f04c60c57db2e128e
https://doi.org/10.1136/bmj.311.7014.1197
https://doi.org/10.1136/bmj.311.7014.1197
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 147(25)
The recent advances in the antiviral therapy of hepatitis C have significantly lowered the threshold for offering such therapy to patients. Sustained virological response rates of 42-46% are achieved after 48 weeks of combination therapy with peginte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d7c7c0b31ecb0e89bb07dbd12268535
https://pubmed.ncbi.nlm.nih.gov/12848055
https://pubmed.ncbi.nlm.nih.gov/12848055
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 94(9)
Minimal hepatic encephalopathy (MHE) refers to subtle neurocognitive and neurophysiological defects in patients with liver cirrhosis without clinical signs of hepatic encephalopathy. Using appropriate diagnostic methods the prevalence of MHE is appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe97e5ffcfe50555e3ff198a7d854da6
https://pubmed.ncbi.nlm.nih.gov/12587235
https://pubmed.ncbi.nlm.nih.gov/12587235